About Viravecs Labs
Data last updated:
Viravecs Labs is a company based in Bengaluru (India) founded in 2014 by Rohan H. Kamat and Srikanth Budnar. It operates as a B2B. Viravecs Labs operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
- Headquarter Bengaluru, India
- Founders Rohan H. Kamat, Srikanth Budnar
- SectorsHealthcare
- PhoneLocked
- WebsiteLocked
- SocialLocked
- Legal Name Viravecs Labs Llp
- Date of Incorporation 13 Oct, 2014
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue$44.31 K (USD)0as on Mar 31, 2019
- Net ProfitNot available
- EBITDANot available
- Latest Funding Round$61.35 K (USD), Grant
May 09, 2017
- Investors
- Employee CountNot available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Viravecs Labs
Investors in Viravecs Labs
Viravecs Labs has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Startup Karnataka.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Support for startups in Karnataka is delivered through policies, funding, and networking services. | Locked | Locked | Locked |
Investor details for Viravecs Labs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Viravecs Labs
Investment portfolio details for Viravecs Labs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Viravecs Labs
Detailed financials for Viravecs Labs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Viravecs Labs Comparisons
Peer comparison for Viravecs Labs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Viravecs Labs
Viravecs Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked | Antibody-siRNA complexes are developed for cancer treatment. | |
| Locked | Locked | Locked | Biomanufacturing technologies are supplied for biopharma antibody and vaccine production. | |
| Locked | Locked | Locked | Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis. | |
| Locked | Locked | Locked | Developing novel drugs based on a proteome-wide ligand and target discovery platform | |
| Locked | Locked | Locked | Dental implants and regenerative dentistry products are developed. | |
| Locked | Locked | Locked | RNA-editing technologies are provided for precision medicine applications. |
Detailed competitors of Viravecs Labs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Viravecs Labs
Complete news archive for Viravecs Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Viravecs Labs
Viravecs Labs was founded in 2014 and raised its 1st funding round 3 years after it was founded.
Viravecs Labs is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Rohan H. Kamat is the current CEO of Viravecs Labs. They have also founded this company.
Annual revenue of Viravecs Labs is $44.31K as on Mar 31, 2019.
Viravecs Labs, established in 2014 and currently in Dissolved stage, focuses on providing healthcare solutions, advancing biotech innovations, gene therapy, and editing services. Provides comprehensive gene therapy and gene editing services for advanced medical solutions. Adapting to market demands with innovation and client-focused strategies.
Viravecs Labs's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
Viravecs Labs has 1 investor. Key investors include Startup Karnataka.